Valeo Financial Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$5K 1908
2020
Q3
$5K Sell
100
-139
-58% -$8.28K ﹤0.01% 1274
2020
Q2
$14K Hold
239
﹤0.01% 1185
2020
Q1
$12K Sell
239
-50
-17% -$2.92K ﹤0.01% 1048
2019
Q4
$17K Hold
289
﹤0.01% 966
2019
Q3
$15K Sell
289
-2
-0.7% -$103 ﹤0.01% 933
2019
Q2
$15K Hold
291
﹤0.01% 929
2019
Q1
$15K Sell
291
-84
-22% -$4.07K ﹤0.01% 863
2018
Q4
$15K Sell
375
-7
-2% -$325 ﹤0.01% 792
2018
Q3
$17K Hold
382
﹤0.01% 832
2018
Q2
$19K Sell
382
-3
-0.8% -$124 ﹤0.01% 788
2018
Q1
$14K Buy
385
+207
+116% +$8.11K ﹤0.01% 846
2017
Q4
$8K Buy
178
+7
+4% +$327 ﹤0.01% 888
2017
Q3
$9K Buy
+171
New +$9.54K ﹤0.01% 737

Other funds holding SYNH

Valeo Financial Advisors's SYNH Position: Q4 2020 in Review

Valeo Financial Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 100 shares — an estimated $5K sold.

Valeo Financial Advisors first reported a position in SYNH in Q3 2017 and held it in 13 quarters. The position peaked at $19K in Q2 2018. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

  • Valeo Financial Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 100 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $5K.
  • Valeo Financial Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 13 quarters.
  • Valeo Financial Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $19K in Q2 2018.
  • 313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Valeo Financial Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.